BASAVARAJAIAH S M | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Dr. BASAVARAJAIAH S M | Medicinal Chemistry | Best Researcher Award

Assistant Pfessorro, Vijaya College, Bangalore

Dr. Basavaraijaiah S. M. is an accomplished chemist with 15 years of teaching and industrial research experience. He has published extensively in national and international journals, authored books, book chapters, and holds patents. Currently, he serves as Coordinator of the P.G. Department of Chemistry at Vijaya College, Bangalore. He has held positions as an Assistant Professor and Principal Scientist in leading institutions and industries. His research focuses on the synthesis and biological activities of heterocyclic compounds. Recognized globally, he is among Stanford University’s Top 2% Scientists (2024). He is an editorial board member for several reputed journals, including Discover Applied Sciences and Journal of Chemistry. Dr. Basavaraijaiah has guided numerous postgraduate students and successfully led funded research projects. He actively organizes national and international chemistry conferences and serves as a BOS and BOE member for various universities, contributing significantly to chemical sciences and education.

Scholar

profile

🎓 Education 

Dr. Basavaraijaiah S. M. holds a Ph.D. in Chemistry (2009) from Gulbarga University, specializing in the synthesis and biological activities of heterocyclic compounds. He completed his M.Sc. in Chemistry (2004) from the same institution and earned his B.Sc. (2002) from Kottureshwara College, Karnataka. His academic journey laid the foundation for his expertise in organic synthesis and medicinal chemistry. Throughout his education, he developed a strong research aptitude, which later led to significant contributions in chemistry through publications, patents, and research projects. His doctoral research focused on nitrogen, oxygen, and sulfur-containing heterocycles, advancing knowledge in pharmaceutical chemistry. Postdoctoral studies at IIT Kanpur further refined his expertise. His academic credentials and continuous learning have positioned him as an authority in chemical sciences, mentoring students and advancing research in organic chemistry.

💼 Experience 

Dr. Basavaraijaiah S. M. has held key academic and industrial positions, currently serving as Coordinator of the P.G. Department of Chemistry at Vijaya College, Bangalore (since 2017). Previously, he was an Assistant Professor at the same institution (2014-2017). His industry experience includes roles as Principal Scientist at Skanda Life Sciences (2013-2014), Senior Scientist (2011-2013), and Group Leader (2010-2011) at LGC Promochem India Pvt. Ltd. He was a Postdoctoral Fellow at IIT Kanpur (2009-2010), enhancing his research in organic chemistry. Earlier, he worked as a Guest Lecturer at Gulbarga University (2007-2008) and as a Trainee Chemist at VB Medicare Pvt. Ltd. (2004-2005). His diverse career integrates academic excellence with industrial applications, contributing to education, research, and scientific advancements.

🏆 Awards & Honors

Dr. Basavaraijaiah S. M. has received global recognition, including being listed among Stanford University’s Top 2% Scientists (2024). His research has earned an H-index of 20 with over 1,400 citations. He has secured multiple grants, including VGST-SPICE funding (2015-16) and a UGC Minor Research Project (₹5 lakh, 2016-2018). He has guided 25 postgraduate students in research and successfully organized several national and international chemistry webinars and workshops. His editorial roles include serving on the boards of Discover Applied Sciences (Springer), Journal of Chemistry (Wiley), and Arkivoc Journal (Arkat USA). Additionally, he is an editorial advisor for Cambridge Scholars Publishing, UK. His contributions to chemical sciences, education, and research have made a significant impact, establishing him as a leader in his field.

🔬 Research Focus

Dr. Basavaraijaiah S. M.’s research focuses on the synthesis and biological activities of heterocyclic compounds, particularly nitrogen, oxygen, and sulfur-based derivatives. His work explores medicinal chemistry applications, aiming to develop novel therapeutic agents. He is actively involved in organic synthesis, green chemistry, and catalytic processes. His contributions extend to drug discovery, material sciences, and sustainable chemistry. He has authored numerous high-impact publications, patents, and book chapters, advancing knowledge in pharmaceutical and industrial chemistry. His research collaborations include academia and industry, fostering innovation in chemical sciences. His expertise in heterocyclic synthesis has led to significant developments in bioactive compounds with potential pharmaceutical applications. He continues to mentor postgraduate students and engage in cutting-edge research, pushing the boundaries of chemistry.

Conclusion

Dr. Basavaraiaiah S. M. is a highly qualified and accomplished researcher with strong credentials in academia, research, and editorial roles. His global recognition, project funding, and research impact make him a strong contender for the Best Researcher Award. Strengthening industry collaborations, international partnerships, and high-impact publications could further solidify his candidacy.

publication

Title: Therapeutic potential of pyrrole and pyrrolidine analogs: an update
Author(s): N Jeelan Basha, S M Basavarajaiah, K Shyamsunder
Year: 2022
Citation: 126

Title: A comprehensive insight on the biological potential of embelin and its derivatives
Author(s): N J Basha, S M Basavarajaiah, S Baskaran
Year: 2022
Citation: 38

Title: Exploration of Indolo [3, 2c] isoquinoline derived triazoles as potential antimicrobial and DNA cleavage agents: synthesis, DFT calculations, and molecular modeling
Author(s): S M Basavarajaiah, J Badiger, N G Yernale, N Gupta
Year: 2023
Citation: 21

Title: Synthesis, spectral analysis, DFT calculations, biological potential and molecular docking studies of indole appended pyrazolo-triazine
Author(s): S M Basavarajaiah, G Y Nagesh, M Javeed, R Bhat
Year: 2023
Citation: 31

Title: Anticancer potential of bioactive molecule luteolin and its analogs: An update
Author(s): N J Basha, S M Basavarajaiah
Year: 2023
Citation: 18

Title: Investigating the molecular interactions of 11-substituted-1-(4-chlorophenyl)-8H-indolo [3, 2-c][1, 2, 4] triazolo [3, 4-a] isoquinolines for Antimicrobial Potential
Author(s): M Ahmed, R Nalini, S M Basavarajaiah
Year: 2024
Citation: 6

Title: Naphtho [2, 1-b] furan derived triazole-pyrimidines as highly potential InhA and Cytochrome c peroxidase inhibitors: synthesis, DFT calculations, drug-likeness profile
Author(s): K S Kiran, M Selvaraj, S M Basavarajaiah
Year: 2023
Citation: 21

 

Syed Luqman Ali | Drug Design | Best Researcher Award

Posted on by ScienceFather

Mr. Syed Luqman Ali | Drug Design | Best Researcher Award

Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan

Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.

Publication Profile

Google scholar

Education

Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelor’s degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.

Research Experience

Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.

Technical Certifications

Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.

Awards and Achievements

Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 📚🖋️🔬

Research Focus

Mr. Syed Luqman Ali’s research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 🧬💻💉

Publication Top Notes

  • Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
    Cited by: 20
    Year: 2023
  • Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica – a hierarchical subtractive proteomics and …
    Cited by: 15
    Year: 2023
  • Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome …
    Cited by: 12
    Year: 2023
  • Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
    Cited by: 9
    Year: 2023
  • Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
    Cited by: 6
    Year: 2023
  • Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
    Cited by: 4
    Year: 2023
  • Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
    Cited by: 1
    Year: 2024
  • Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
    Cited by: 1
    Year: 2024
  • Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
    Cited by: 1
    Year: 2024
  • Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
    Cited by: 1
    Year: 2024
  • Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
    Cited by: 1
    Year: 2024
  • Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
    Cited by: 1
    Year: 2025
  • Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    Cited by: 1
    Year: 2024
  • A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
    Cited by: –
    Year: 2024
Conclusion

Mr. Ali’s solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.

 

 

 

 

 

 

Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Posted on by ScienceFather

Prof. Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Professor Faisal Al-Akayleh, an editorial board member of the Jordan Journal of Pharmaceutical Sciences.  university of Petra, Jordan

🌟 Professor Faisal T. Al-Akayleh, Ph.D. is a distinguished expert in pharmaceutics and pharmaceutical technology, serving as the Head of the Department of Pharmaceutics and Pharmaceutical Technology at the University of Petra, Amman, Jordan. With a robust academic and professional background, Professor Al-Akayleh has made remarkable contributions as a pharmaceutical researcher, inventor, and consultant. He has authored five patents in the fields of nanotechnology, pharmaceutical science, and environmental applications. His innovative spirit is reflected in his leadership roles and impactful projects in drug delivery and nanotechnology. 💊🔬

Publication Profile

Education

🎓 Ph.D. in Pharmaceutics and Pharmaceutical Technology – Professor Al-Akayleh’s academic journey is marked by his expertise in pharmaceutics, enabling him to advance the pharmaceutical industry with groundbreaking innovations. His education laid the foundation for his significant contributions to pharmaceutical technology and material science. 📚

Experience

📈 With years of experience in academia and the pharmaceutical industry, Professor Al-Akayleh has served as a technical manager and consultant for various pharmaceutical companies. As an associate professor, he has led groundbreaking research projects and collaborated on numerous industry-funded initiatives. His leadership extends to his roles as a board member of the Jordan Journal of Pharmaceutical Sciences and the University of Petra Pharmaceutical Center. He also chairs the Ethical Approval Committee at the University of Petra. 🧪

Awards and Honors

🏆 Professor Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence (2018) for his collaborative project on developing an oral insulin delivery system. His dedication to innovation has garnered recognition for advancing pharmaceutical research and development. ✨

Research Focus

🔍 Professor Al-Akayleh specializes in drug delivery systems, nanotechnology, pharmaceutical material science, and environmental sustainability. His research addresses critical challenges in developing innovative drug formulations, including nanoparticles for improved skin permeation and novel excipients for enhanced drug delivery. 🌐

Conclusion

Professor Faisal T. Al-Akayleh is a trailblazer in pharmaceutical sciences, combining academic excellence with industrial expertise to deliver innovative solutions. His commitment to advancing pharmaceutics and nanotechnology continues to inspire scientific progress and foster meaningful collaborations. 🌟

Publications

Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals (2024)
Published in Pharmaceuticals, cited by 10 articles.

Novel therapeutic deep eutectic system for the enhancement of ketoconazole antifungal activity and transdermal permeability (2024)
Published in Journal of Molecular Liquids, cited by 15 articles.

AI-Driven Physical Rehabilitation Strategies in Post-Cancer Care (2024)
Presented at IEEE ICCR 2024 Conference, cited by 5 articles.

What We Know About the Actual Role of Traditional Probiotics in Health and Disease (2024)
Published in Probiotics and Antimicrobial Proteins, cited by 12 articles.

Utilizing olive leaves biomass as an efficient adsorbent for ciprofloxacin removal (2024)
Published in Environmental Monitoring and Assessment, cited by 8 articles.